The Role of EGFR Mutations in Pancreatic Cancer Patients Receiving Gemcitabine With or Without Erlotinib

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2005
The purpose of this study is to investigate the influence of epidermal growth factor receptor mutations on the efficacy of erlotinib and gemcitabine in metastatic pancreatic cancer.
Epistemonikos ID: e9f1fe3d908227b7f0fefb33ac56f078b234c741
First added on: May 11, 2024